AVTX
Avalo Therapeutics Inc.
$14.37
-$1.55(-9.77%)
43
Overall
60
Value
33
Tech
36
Quality
Market Cap
$281.44M
Volume
1.28M
52W Range
$3.39 - $20.72
Target Price
$37.89
EPS Estimates Overview
| Current Quarter | $-1.07 | Next Quarter | $-0.94 |
| Current Year | $-4.1 | Next Year | $-2.93 |
| QoQ Growth | +12.1% | YoY Growth | +28.5% |
| 3Y EPS CAGR | +91.8% | Target Price | $37.89 |
| Consensus | Buy | Upside | +163.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AVTX | $14.37 | -9.8% | 1.28M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |